A detailed history of Greenwood Gearhart Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Greenwood Gearhart Inc holds 789 shares of LLY stock, worth $627,783. This represents 0.06% of its overall portfolio holdings.

Number of Shares
789
Previous 795 0.75%
Holding current value
$627,783
Previous $719,000 2.78%
% of portfolio
0.06%
Previous 0.07%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$772.14 - $960.02 $4,632 - $5,760
-6 Reduced 0.75%
789 $699,000
Q2 2024

Aug 07, 2024

SELL
$724.87 - $909.04 $5,074 - $6,363
-7 Reduced 0.87%
795 $719,000
Q1 2024

May 15, 2024

BUY
$592.2 - $792.28 $4,737 - $6,338
8 Added 1.01%
802 $623,000
Q4 2023

Feb 13, 2024

SELL
$525.19 - $619.13 $56,720 - $66,866
-108 Reduced 11.97%
794 $462,000
Q2 2023

Aug 14, 2023

SELL
$350.74 - $468.98 $1,402 - $1,875
-4 Reduced 0.44%
902 $423,000
Q1 2023

May 15, 2023

SELL
$310.63 - $364.82 $1,242 - $1,459
-4 Reduced 0.44%
906 $311,000
Q4 2022

Feb 15, 2023

SELL
$321.55 - $374.67 $6,109 - $7,118
-19 Reduced 2.05%
910 $332,000
Q3 2022

Nov 15, 2022

BUY
$296.48 - $337.87 $1,185 - $1,351
4 Added 0.43%
929 $300,000
Q2 2022

Aug 16, 2022

SELL
$278.73 - $327.27 $4,738 - $5,563
-17 Reduced 1.8%
925 $300,000
Q4 2021

Feb 15, 2022

SELL
$224.85 - $279.04 $1,349 - $1,674
-6 Reduced 0.63%
942 $260,000
Q3 2021

Nov 15, 2021

BUY
$221.6 - $272.71 $1,329 - $1,636
6 Added 0.64%
948 $219,000
Q2 2021

Aug 13, 2021

BUY
$180.55 - $233.54 $170,078 - $219,994
942 New
942 $216,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Greenwood Gearhart Inc Portfolio

Follow Greenwood Gearhart Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Greenwood Gearhart Inc, based on Form 13F filings with the SEC.

News

Stay updated on Greenwood Gearhart Inc with notifications on news.